Sysmex base_Aktie

Sysmex base_Mitarbeiter 2025

Sysmex base_Mitarbeiter

8.200,00

components_StockPageHeader__3

6869.T

components_StockPageHeader__4

JP3351100007

components_StockPageHeader__5

897966

pages_kennzahlen_[key]_[isin]__39

Sysmex Aktienanalyse

pages_kennzahlen_[key]_[isin]__1

Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex ist eines der beliebtesten Unternehmen auf Eulerpool.com.

pages_kennzahlen_[key]_[isin]__85

pages_kennzahlen_[key]_[isin]__81

pages_dividenden_[isin]_index__2

components_kpi_EmployeesFaqs_0

components_kpi_EmployeesFaqs_1

components_kpi_EmployeesFaqs_2

components_kpi_EmployeesFaqs_3

components_kpi_EmployeesFaqs_4

components_kpi_EmployeesFaqs_5

components_kpi_EmployeesFaqs_6

components_kpi_EmployeesFaqs_7

components_kpi_EmployeesFaqs_8

components_kpi_EmployeesFaqs_9

components_kpi_EmployeesFaqs_10

components_kpi_EmployeesFaqs_11

components_kpi_EmployeesFaqs_12

components_kpi_EmployeesFaqs_13

components_kpi_EmployeesFaqs_14

components_kpi_EmployeesFaqs_15

components_kpi_EmployeesFaqs_16

components_kpi_EmployeesFaqs_17

components_kpi_EmployeesFaqs_18

components_kpi_EmployeesFaqs_19

components_kpi_EmployeesFaqs_20

components_kpi_EmployeesFaqs_21

components_kpi_EmployeesFaqs_22

components_kpi_EmployeesFaqs_23

components_kpi_EmployeesFaqs_24

components_kpi_EmployeesFaqs_25

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Sysmex kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

components_kpi_Savingsplan_0